Janux Therapeutics Inc

NASDAQ:JANX   4:00:00 PM EDT
37.65
-0.27 (-0.71%)
7:41:24 PM EDT: $37.30 -0.35 (-0.93%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.95B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.66 Million
Adjusted EPS-$0.34
See more estimates
10-Day MA$38.56
50-Day MA$24.27
200-Day MA$13.80
See more pivots

Janux Therapeutics Inc Stock, NASDAQ:JANX

10955 Vista Sorrento Parkway, Suite 200, San Diego, California 92130
United States of America
Phone: +1.858.751.4493
Number of Employees: 64

Description

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.